This short case describes Indian drug manufacturer Ranbaxy settlements with Pfizer and AstraZeneca and Daiichi Kangyo acquisition of a majority stake in Ranbaxy in 2008 has made.

This short case describes Indian drug manufacturer Ranbaxy settlements with Pfizer and AstraZeneca and Daiichi Kangyo acquisition of a majority stake in Ranbaxy in 2008 has made.
«Hide

from
Robert C. Pozen
Source: Harvard Business School
2 pages.
Release Date: 2 July 2008. Prod #: 609010-PDF-ENG
Recent developments in Ranbaxy case solution HBR Case